Ganesh Barkade
VIDWAN ID: 108386

Dr Ganesh Barkade

Male Doctor of Philosophy
Assistant Professor (Grade-I)
Dr Vithalrao Vikhe Patil Foundations College of Pharmacy
Maharashtra
Expertise: Medicinal Chemistry
35 Publications
1 Projects
17 Scopus Citations
48 CrossRef
5 Years 1 Month Total Experience
Publications
35 Total
Articles
35
Activity

No publication activity to display.

Scopus Scopus
17 Citations
2 h-index
CrossRef CrossRef
48 Citations
4 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

Best Research Scholar-2016
2016
Dr.Vithalrao Vikhe Patil College of Pharmacy, Ahmednagar
Best Young Researcher Award-2021
2021
Novel Research Academy
Emerging Scientist Award-2022
2022
International Research Awards on Science, Technology and Management, held on 14 & 15-May-2022, Chenn

Community & Membership

Institutional Research Committee
Member
Jan 2022
Institutional Cultural Committee
Member
Jan 2021
Maharashtra State Pharmacy Council
Registered Pharmacist
Jan 2016
Association of Pharmaceutical Teachers of India (APTI)
Life time member
Jan 2025

Personal Details

Doctor of Philosophy
2024
South Texas Veterans Health Care System, San Antonio, Texas, USA
Master of Arts
2018
South Texas Veterans Health Care System, San Antonio, Texas, USA
Master of Arts
2016
South Texas Veterans Health Care System, San Antonio, Texas, USA
Assistant Professor (Grade-I)
Aug 2021 – Present
Dr Vithalrao Vikhe Patil Foundations College of Pharmacy
Medical and Health Sciences
Medicinal Chemistry

Related Profiles

Scholarly Work

Substituted 1, 3-Thiazolidin-4-one compounds and derivatives thereof and its anticancer activity
Completed
Agency: Indian Council of Medical Research Role: Other
No Data Found

There is currently nothing to display here.

Substituted 1, 3-Thiazolidin-4-one compounds and derivatives thereof and its anticancer activity

Ganesh Barkade
- Patent No. : 519043 Filed : 27-08-2022
Published : 07-10-2022 Granted

Scholarly Publications

Structural Requirement of 1,3-Thiazolidine-4-ones to Inhibit Polo Like Kinase 1 as Anticancer Agents

Other
Year: 2019.

Anticoagulant activity of calotropis gigantea leaves

Open Access
Journal Article
Research Journal of Pharmacy and Technology. Year: 2016. Volume: 9 , Issue: 9 , Pages: 1493 .
Authors: Wadekar, J.B.; Sawant, R.L.; Sanklecha, K.R.; Ghodechor, A.S.; Sable, P.B.; Barkade, G.D.

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF OLANZEPINE AND ESCITALOPRAM OXALATE BY USING HPLC AND UV SPECTROPHOTOMETRIC METHOD

Journal Article
Year: 2019.

REPURPOSING AND PHYTOCHEMICAL INVESTIGATION OF SALACIA OBLONGA ROOT EXTRACT RESPONSIBLE ANTICANCER ACTIVITY AGAINST BREAST CANCER CELL LINE (MCF-7)

Journal Article
Year: 2019.

Development and Validation of simple UV Spectrophotometric Method for the Determination of Racecodotril both in Bulk and Marketed Dosage Formulations

Other
Year: 2020.
Authors: Rushikesh D. Ukirde; Ramesh L. Sawant; Ganesh D. Barkade

Molecular Docking Studies of 1, 3- Thiazolidin-4-Ones as Potential Human Polo Like Kinase 1 (Plk 1) Inhibitors

Journal Article
Year: 2020.
Authors: Ramesh L. Sawant; Jyoti B. Wadekar; Rushikesh D. Ukirde; Ganesh D. Barkade

Development and Validation of simple UV Spectrophotometric Method for the Determination of Racecodotril both in Bulk and Marketed Dosage Formulations

Open Access
Journal Article
INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE. Year: 2020. Volume: 11 , Issue: 03 , Pages: 334-337 .
Authors: Rushikesh D. Ukirde; Ramesh L. Sawant; Ganesh D. Barkade

Synthesis and Biological evaluation of Novel Quinazoline derivatives as Anticancer, Antibacterial and Antifungal agents

Journal Article
Year: 2021.
Showing 1 to 8 of 35 publications